Taken together, our studies have demonstrated essential role of ERα and STAT5b in EGF/EGFR induced activation of PRLR gene transcription/expression in breast cancer cells via STAT5b interaction with ERα and complex formation with Sp1/C/EBPβ at the PRLR promoter in the absence of estrogen. Here, STAT5B is linked to breast carcinoma.